Protocol Index	

If this file opens in Compatibility Mode using Microsoft Word, convert to the latest document format to avoid potential formatting issues.	

OP RESEARCH PRO00038239 NCT06413498 LEUKAPHERESIS	

Types:      Research Oncology Treatment
Synonyms:  KT-US-679-0788

Leukapheresis (Within 10 days after randomization)	Repeat 1 time	Cycle length: 1 day	Day 1	Perform every 1 day x1		Provider Communication
  	ONC PROVIDER COMMUNICATION	Interval: --	Occurrences: --	Comments:	Please refer to Study Protocol for any questions or discrepancies. See Schedule of Events Calendar for sequence of diagnostic tests, examinations, and treatment administration:    KT-US-679-0788_Ganguly
			Nursing Orders
  	ONC NURSING COMMUNICATION 14	Interval: --	Occurrences: --	Comments:	Physical exam - Including assessment of EMD. 
Assessment of EMD for participants with confirmed EMD at screening (until CR/sCR or disease progression).
		  	MEASURE WEIGHT	Interval: --	Occurrences: --		  	VITAL SIGNS - T/P/R/BP	Interval: --	Occurrences: --	Comments:	Blood pressure, heart rate, respiration rate, oxygen saturation and temperature.
		  	PULSE OXIMETRY	Interval: --	Occurrences: --		  	ONC NURSING COMMUNICATION 16	Interval: --	Occurrences: --	Comments:	ECOG performance status
		  	ONC NURSING COMMUNICATION 22	Interval: --	Occurrences: --	Comments:	Collection of AE's and SAE's
		  	ONC NURSING COMMUNICATION 25	Interval: --	Occurrences: --	Comments:	Concomitant medications and procedures
			Labs
  	COMPREHENSIVE METABOLIC PANEL	Interval: --	Occurrences: --		  	CBC WITH PLATELET AND DIFFERENTIAL	Interval: --	Occurrences: --		  	LACTIC ACID LEVEL	Interval: --	Occurrences: --	Comments:	As clinically indicated
		  	MAGNESIUM LEVEL	Interval: --	Occurrences: --		  	LDH	Interval: --	Occurrences: --		  	TOTAL BILIRUBIN	Interval: --	Occurrences: --		  	BUN LEVEL	Interval: --	Occurrences: --		  	URIC ACID LEVEL	Interval: --	Occurrences: --	Comments:	As clinically indicated
		  	C-REACTIVE PROTEIN	Interval: --	Occurrences: --		  	FERRITIN LEVEL	Interval: --	Occurrences: --		  	HCG QUALITATIVE, SERUM SCREEN	Interval: --	Occurrences: --	Comments:	for FCBP
			Research Labs
  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Repeat at Leukapheresis if screening assessment was performed >14 days before this visit
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	SPEP/SIFE: Repeat at Leukapheresis if screening assessment was performed >14 days before this visit
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Repeat at Leukapheresis if screening assessment was performed >14 days before this visit
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Repeat at Leukapheresis if screening assessment was performed GREATER than 14 days before this visit.
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --	Comments:	Optional. Can be performed any time between leukapheresis and start of lymphodepletion chemotherapy if clinically indicated. Order Lumbar Puncture procedure as appropriate.
		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --		  	RESEARCH STUDY SPECIMEN	Interval: --	Occurrences: --